Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Chad

Chad

The projected revenue for the COVID-19 Vaccines market in Chad is expected to reach US$31.93m in 2024.
This indicates a significant potential for growth in the market.
Furthermore, it is anticipated that the revenue will exhibit a Compound Annual Growth Rate (CAGR) of -18.37% from 2024 to 2029.
Consequently, the market volume is estimated to reach US$11.57m by 2029.
In terms of global comparison, it is noteworthy that United States is projected to generate the highest revenue in the COVID-19 Vaccines market.
The estimated revenue for the United States in 2024 is US$4,389,000.00k.
This demonstrates the significant market position of the United States in the global context.
Chad, a country in Central Africa, faces significant challenges in the distribution and access to COVID-19 vaccines due to its geographical and infrastructural limitations.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

The COVID-19 pandemic has affected the world in unprecedented ways, and the race to develop vaccines has been a major focus of the healthcare industry. Chad, a landlocked country in central Africa, has been hit hard by the pandemic, with a significant number of cases and deaths reported. The COVID-19 vaccines market in Chad has been developing in a certain way due to various factors.

Customer preferences: The customer preferences in Chad are similar to those in other African countries. The majority of people are hesitant to take the vaccine due to misinformation and mistrust. Additionally, the lack of awareness about the vaccines and their benefits has contributed to the slow uptake of vaccines. The government has been working to educate the public and promote the importance of vaccination to increase acceptance.

Trends in the market: The COVID-19 vaccines market in Chad has been developing slowly due to various factors. The country has been facing challenges in securing enough doses of vaccines due to global supply constraints. Additionally, the infrastructure and resources required for the storage and distribution of the vaccines are limited. The government has been working to address these issues and increase the availability of vaccines.

Local special circumstances: Chad is a low-income country with limited resources, which has made it difficult for the government to secure enough doses of vaccines. The country has also been facing other challenges, such as political instability and conflicts, which have affected the distribution of vaccines. Additionally, the country has a large rural population, which makes it difficult to reach everyone with the vaccines.

Underlying macroeconomic factors: The COVID-19 vaccines market in Chad has been affected by various underlying macroeconomic factors. The country's economy is heavily dependent on oil exports, which have been hit hard by the pandemic. This has limited the government's ability to invest in healthcare and other essential services. Additionally, the country has a high poverty rate, which has made it difficult for people to access healthcare services, including vaccines. The government has been working to address these issues and increase investment in the healthcare sector.In conclusion, the COVID-19 vaccines market in Chad has been developing slowly due to various factors, including limited supply, infrastructure challenges, and low awareness and acceptance among the population. The government has been working to address these issues and increase the availability and uptake of vaccines. However, the country's underlying macroeconomic factors, such as its dependence on oil exports and high poverty rate, have also affected the development of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.